| PENUMBRA INC. |
| USA |
| Gesundheit |
| US70975L1070 / A14Y65 |
| 0P8 (Frankfurt) / PEN (NYSE) |
| FRA:0P8, ETR:0P8, 0P8:GR, NYSE:PEN |
| - |
| https://www.penumbrainc.c.. |
|
Penumbra Inc. is a prominent player in the healthcare sector, focusing primarily on the development and commercialization of innovative medical devices. Known for its customer-centric approach, the co..
>Volltext.. |
| 11585.53 Mio. EUR |
| 11306.5 Mio. EUR |
| 1210.62 Mio. EUR |
| 178.29 Mio. EUR |
| 153.25 Mio. EUR |
| 3.94 EUR |
| 189.48 Mio. EUR |
| 161.19 Mio. EUR |
| 205.84 Mio. EUR |
| 2.97 |
| 3.56% |
| 1017.72% |
| - |
| - |
| - |
| - |
| PENUMBRA |
| 04.03.26 |